Title
Management of Cancer Cachexia
Authoring Organization
Publication Month/Year
July 12, 2023
Last Updated Month/Year
February 15, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
The purpose of this guideline is to provide evidence-based guidance on the optimal approach for the treatment of cachexia in patients with advanced cancer. Cachexia is a multifactorial syndrome characterized by loss of appetite, weight, and skeletal muscle, leading to fatigue, functional impairment, increased treatment-related toxicity, poor quality of life, and reduced survival.
Target Patient Population
Adult patients with advanced cancer and loss of appetite, body weight, and/or lean body mass (ie, skeletal muscle).
Target Provider Population
Clinicians who provide care to adult patients with cancer, as well as patients and caregivers.
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Home health, Hospital, Long term care
Intended Users
Dietician nutritionist, nurse, nurse practitioner, health systems pharmacist, physician, physician assistant, social worker
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D002100 - Cachexia
Keywords
cancer, Cancer Cachexia, nutritional interventions, pharmacological interventions, precachexia, refractory cachexia, cachexia
Source Citation
Eric J. Roeland, MD; Kari Bohlke, ScD; Vickie E. Baracos, PhD; Management of Cancer Cachexia: ASCO Guideline update. J Clin Oncol. 2023 July 12. doi: 10.1200/JCO.23.01280
Eric J. Roeland, MD; Kari Bohlke, ScD; Vickie E. Baracos, PhD; Eduardo Bruera, MD; Egidio del Fabbro, MD; Suzanne Dixon, MPH, MS, RD; Marie Fallon, MD; Jørn Herrstedt, MD, DMSci; Harold Lau, MD; Mary Platek, PhD, MS, RD; Hope S. Rugo, MD; Hester H. Schnipper, LICSW; Thomas J Smith, MD; Winston Tan, MD; Charles L. Loprinzi, MD. Management of Cancer Cachexia: ASCO Guideline. J Clin Oncol. 2020 May 20 doi: 10.1200/JCO.20.00611